Description

Ethyl 6-Methyl-2-Phenylimidazo[1,2-A]Pyridine-3-Carboxylate is a high-purity, advanced pharmaceutical intermediate belonging to the imidazopyridine class of heterocyclic compounds. This compound matters as a critical building block in modern medicinal chemistry, enabling the synthesis of novel active pharmaceutical ingredients (APIs) with targeted therapeutic effects. It is primarily needed by research institutions and pharmaceutical manufacturers engaged in the development of new drugs, particularly for central nervous system (CNS) and anti-inflammatory applications.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of novel drug candidates, especially those targeting neurological pathways.
• Medicinal Chemistry Research: Used in lead optimization and structure-activity relationship (SAR) studies for developing new therapeutic agents.
• Active Pharmaceutical Ingredient (API) Synthesis: A crucial building block in the multi-step manufacturing process of final drug substances.
• Contract Research & Development (CRO/CDMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.
• Reference Standard: Can be utilized as an analytical standard for quality control and method development in pharmaceutical analysis.
• Academic Research: Employed in university and institutional labs for studying heterocyclic chemistry and developing new synthetic methodologies.

Basic Information

Product Name	Ethyl 6-Methyl-2-Phenylimidazo[1,2-A]Pyridine-3-Carboxylate
CAS No.	127801-87-0
Molecular Formula	C17H16N2O2
Molecular Weight	280.32 g/mol
Synonyms	Ethyl 6-Methyl-2-Phenylimidazo[1,2-a]pyridine-3-carboxylate; 6-Methyl-2-phenylimidazo[1,2-a]pyridine-3-carboxylic Acid Ethyl Ester; Imidazo[1,2-a]pyridine-3-carboxylic Acid, 6-Methyl-2-Phenyl-, Ethyl Ester; Ethyl 2-Phenyl-6-methylimidazo[1,2-a]pyridine-3-carboxylate; 127801-87-0; Zolpidem Intermediate Derivative; Zolpidem Related Compound
EINECS	Contact for details

Quality Control

Our Ethyl 6-Methyl-2-Phenylimidazo[1,2-A]Pyridine-3-Carboxylate is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all critical quality attributes. Our commitment to quality supports compliance in regulated pharmaceutical development environments.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from heat, sparks, and open flame. For long-term storage, consider inert gas purging to maintain stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Related Substances (HPLC)	Individual impurity ≤ 0.5%, Total impurities ≤ 1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.